Filing Details
- Accession Number:
- 0001367644-19-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-12 09:52:19
- Reporting Period:
- 2019-11-08
- Accepted Time:
- 2019-11-12 09:52:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1685720 | C Kathryn Zoon | 400 Professional Drive Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-11-08 | 3,082 | $54.15 | 18,412 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon.
- The price reported is the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.69 to $54.72.